Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04288271 · ClinicalTrials.gov registry record · NA

Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3

A NA study, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

Completed
Registry status
NA
Development phase
96
Enrollment target

NCT04288271 is a NA study that has completed, run by McGill University Health Centre/Research Institute of the McGill University Health Centre. The registered enrollment target is 96 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04288271, a NA study, has completed, sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre.

COMPLETED
Registry status
NA
Development phase
96 participants
Enrollment target

Study Summary

Medication non-adherence is a major problem in kidney transplant recipients; young people 12-24 years of age are at particularly high risk for non-adherence and graft failure compared to young children and adults. Given that poor medication contributes greatly to graft failure, clinically feasible and effective interventions are urgently needed to improve adherence, survival, and quality of life in this population. The broad aim of this prospective, 3-stage, sequential study is to improve medication adherence in adolescent kidney transplant recipients by: 1) adapting the successful Teen Adherence in Kidney transplant Effectiveness of Intervention Trial (TAKE-IT) intervention for use in 'real world' clinical care, 2) designing and testing a new portable electronic pillbox and companion tracking website interface, and 3) preliminary testing of the adapted intervention.

Interventions

  • BEHAVIORAL Adherence Intervention
  • OTHER Healthy living education intervention

Trial Details

FieldValue
Enrollment Target 96 participants
Start Date 2022-02-04
Est. Completion 2023-06-30
Phase NA

What the Registry Record Tells You About NCT04288271

The ClinicalTrials.gov registry entry for NCT04288271 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Adherence Intervention is the first listed.

NCT04288271 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04288271 about?

NCT04288271 is a clinical study titled "Teen Adherence in KidnEy Transplant Improving Tracking To Optimize Outcomes - Stage 3". Medication non-adherence is a major problem in kidney transplant recipients; young people 12-24 years of age are at particularly high risk for non-adherence and graft failure compared to young children and adults. Given that poor medication contributes greatly to graft failure, clinically feasible a...

What is the current status of trial NCT04288271?

This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2022-02-04. Estimated completion is 2023-06-30.

What interventions are being tested in trial NCT04288271?

The interventions under investigation include: Adherence Intervention (BEHAVIORAL), Healthy living education intervention (OTHER).

Who is sponsoring clinical trial NCT04288271?

This trial is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.